Toggle navigation
Home
Search
Services
Blog
Contact
About
Cloning and Characterization of Mysoin Ix in PC12 Cells
Joyce, Myra P.
Columbia University (N.Y.), New York, NY, United States
Search grants from Myra Joyce
Search grants from Columbia University (N.Y.)
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Anti-inflammatory Therapy with Low Dose Methotrexate for Reduction of PAD
Pharmacogenetics of Methotrexate in Rheumatoid Arthritis
Neuronal Low Threshold Calcium Channels - Neuroscience
Perinatal Transmission of HIV and Related Retroviruses
A Homo-Claisen Approach to Helenalin & Confertiflorin
Recently added grants:
Genetic targeting of hippocampal CA2 pyramidal neurons
Exploring Antisense Oligonucleotides as a potential therapy for Autosomal Dominant Leukodystrophy
CNS in Congenital DM1: Pathogenesis and Therapeutic Opportunities
Regulation of hippocampal morphogenesis and homeostasis by the E3 ubiquitin ligase CRL5
Leadership Administrative Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32NS009431-02
Application #
2261221
Study Section
Biological Sciences 2 (BIOL)
Project Start
1994-03-01
Project End
Budget Start
1994-03-01
Budget End
1995-02-28
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Institution
Name
Columbia University (N.Y.)
Department
Pathology
Type
Schools of Medicine
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Related projects
NIH 1994
F32 NS
Cloning and Characterization of Mysoin Ix in PC12 Cells
Joyce, Myra P. / Columbia University (N.Y.)
NIH 1993
F32 NS
Cloning and Characterization of Mysoin Ix in PC12 Cells
Joyce, Myra P. / Columbia University (N.Y.)
Comments
Be the first to comment on this grant